Home » Topics » BioWorld Science

BioWorld Science
RSS

A designer supramolecule AK-750 amplifies innate immune responses in preclinical models of cancer

July 17, 2018

Specific redox enzyme helps reverse fibrosis

July 17, 2018

Aging, ARCH and AML

July 17, 2018

Cognitive, somatic stabilization by treatment with IgG-IDUA fusion protein in children with MPS I

July 17, 2018

MaxCyte's cleared to begin clinical study of CAR therapy MCY-M11

July 16, 2018

First-in-human study explores use of BAY-2287411 in mesothelin-expressing tumors

July 16, 2018

Brain-targeted gene editing using CRISPR-Gold in mice models of fragile X syndrome

July 16, 2018

BGI-Shenzhen synthesizes new cancer vaccines

July 16, 2018

RegenxBio begins first-in-human study with RGX-121 gene therapy for Hunter's syndrome

July 16, 2018

FDA approves Xtandi for nonmetastatic castration-resistant prostate cancer

July 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...